197 related articles for article (PubMed ID: 19557804)
1. Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors.
Vendrell M; Soriano A; Casadó V; Díaz JL; Lavilla R; Canela EI; Lluís C; Franco R; Albericio F; Royo M
ChemMedChem; 2009 Sep; 4(9):1514-22. PubMed ID: 19557804
[TBL] [Abstract][Full Text] [Related]
2. A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D(1) and D(2) dopamine receptors.
Molero A; Vendrell M; Bonaventura J; Zachmann J; López L; Pardo L; Lluis C; Cortés A; Albericio F; Casadó V; Royo M
Eur J Med Chem; 2015 Jun; 97():173-80. PubMed ID: 25969169
[TBL] [Abstract][Full Text] [Related]
3. A hybrid indoloquinolizidine peptide as allosteric modulator of dopamine D1 receptors.
Soriano A; Vendrell M; Gonzalez S; Mallol J; Albericio F; Royo M; Lluís C; Canela EI; Franco R; Cortés A; Casadó V
J Pharmacol Exp Ther; 2010 Mar; 332(3):876-85. PubMed ID: 20026675
[TBL] [Abstract][Full Text] [Related]
4. N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.
Herm L; Berényi S; Vonk A; Rinken A; Sipos A
Bioorg Med Chem; 2009 Jul; 17(13):4756-62. PubMed ID: 19454369
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
Abaimov DA; Zimin IA; Kovalev GI
Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
[TBL] [Abstract][Full Text] [Related]
6. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
[TBL] [Abstract][Full Text] [Related]
7. Biotin ergopeptide probes for dopamine receptors.
Vendrell M; Molero A; González S; Pérez-Capote K; Lluis C; McCormick PJ; Franco R; Cortés A; Casadó V; Albericio F; Royo M
J Med Chem; 2011 Feb; 54(4):1080-90. PubMed ID: 21280602
[TBL] [Abstract][Full Text] [Related]
8. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay.
Jiang N; Ou-Yang KQ; Cai SX; Hu YH; Xu ZL
Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
10. Identification of human dopamine receptors agonists from Chinese herbs.
Zhang YL; Zhang HQ; Liu XY; Hua SN; Zhou LB; Yu J; Tan XH
Acta Pharmacol Sin; 2007 Jan; 28(1):132-9. PubMed ID: 17184593
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of inverse agonist action at D2 dopamine receptors.
Roberts DJ; Strange PG
Br J Pharmacol; 2005 May; 145(1):34-42. PubMed ID: 15735658
[TBL] [Abstract][Full Text] [Related]
12. Z1046: biochemical characterization of its dopaminergic activity.
Fantoni M; Moriggi E; Bisiani C; Masotto C; Pocchiari F; Semeraro C
Acta Physiol Hung; 1996; 84(3):279-80. PubMed ID: 9219606
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
Zhang J; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
[TBL] [Abstract][Full Text] [Related]
15. Novel ergopeptides as dual ligands for adenosine and dopamine receptors.
Vendrell M; Angulo E; Casadó V; Lluis C; Franco R; Albericio F; Royo M
J Med Chem; 2007 Jun; 50(13):3062-9. PubMed ID: 17539620
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor dimers and receptor-blocking peptides.
Ng GY; O'Dowd BF; Lee SP; Chung HT; Brann MR; Seeman P; George SR
Biochem Biophys Res Commun; 1996 Oct; 227(1):200-4. PubMed ID: 8858125
[TBL] [Abstract][Full Text] [Related]
17. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
[TBL] [Abstract][Full Text] [Related]
19. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
[TBL] [Abstract][Full Text] [Related]
20. A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.
Liu D; Dijkstra D; de Vries JB; Wikström HV
Bioorg Med Chem; 2008 Mar; 16(6):3438-44. PubMed ID: 18313303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
